Zilxi FDA Approval History
FDA Approved: Yes (First approved May 28, 2020)
Brand name: Zilxi
Generic name: minocycline
Dosage form: Topical Foam
Previous Name: FMX103
Company: Foamix Pharmaceuticals Ltd.
Treatment for: Rosacea
Zilxi (minocycline) is a topical tetracycline formulation indicated for the treatment of inflammatory lesions of rosacea in adults.
Development Timeline for Zilxi
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.